| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (P10S) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (G29R) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (T18I) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (missense variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Deletion (nonsense +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (W17*) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | LOC130068869, DNASE1L1 +1 more (L19fs) | Deletion (frameshift variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (missense variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (A42T) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | TAFAZZIN, DNASE1L1 +1 more (A42fs) | Deletion (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (M1V) | Single nucleotide variant (missense variant +3 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (Y31C) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, TAFAZZIN (M39I +1 more) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (M1I) | Single nucleotide variant (missense variant +3 more) | 3-Methylglutaconic aciduria type 2 | |
| | TAFAZZIN, DNASE1L1 (Y56C +1 more) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (F34I) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (K6N) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | LOC130068869, TAFAZZIN +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype +1 more | |
| | DNASE1L1, LOC130068869 +1 more (V23I) | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | TAFAZZIN, DNASE1L1 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | LOC130068869, TAFAZZIN +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype | |
| | DNASE1L1, LOC130068869 +1 more (P13S) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | DNASE1L1, LOC130068869 +1 more (P14Q) | Single nucleotide variant (missense variant +2 more) | not provided | |
| | LOC130068869, TAFAZZIN +1 more (P8fs) | Duplication (frameshift variant +2 more) | not provided | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Deletion | not provided | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not provided | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not provided | |
| | TAFAZZIN, DNASE1L1 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | TAFAZZIN, DNASE1L1 +1 more (W39*) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | GPathogenic/Likely pathogenic |
| | DNASE1L1, LOC130068869 +1 more (T16S) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (W17R) | Single nucleotide variant (5 prime UTR variant +2 more) | Endocardial fibroelastosis +2 more | |
| | TAFAZZIN, DNASE1L1 +1 more (T30I) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (F9L) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not provided +2 more | |
| | DNASE1L1, LOC130068869 +1 more (P10R) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | DNASE1L1, LOC130068869 +1 more (W17C) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | LOC130068869, TAFAZZIN +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not specified | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not provided +2 more | |
| | | Duplication (nonsense +1 more) | Left ventricular noncompaction | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Cardiomyopathy +2 more | GConflicting classifications of pathogenicity |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Primary dilated cardiomyopathy +4 more | |
| | DNASE1L1, LOC130068869 +1 more | Deletion (no sequence alteration +2 more) | Endocardial fibroelastosis +3 more | |
| | LOC130068869, TAFAZZIN +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not specified | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype +2 more | |
| | TAFAZZIN, DNASE1L1 +1 more (V5L) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | |
| | TAFAZZIN, LOC130068869 +1 more (P46L) | Single nucleotide variant (5 prime UTR variant +2 more) | not specified | |
| | | Single nucleotide variant (no sequence alteration +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | LOC130068869, TAFAZZIN +1 more (E38D) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |